ID   PNUi003-B
AC   CVCL_C1VF
SY   SCZ0714_4-7
DR   hPSCreg; PNUi003-B
DR   Wikidata; Q114312677
RX   PubMed=35944312;
CC   From: Department of Psychiatry, Nagoya University Graduate School of Medicine; Nagoya; Japan.
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; 2183; VPS13B; Zygosity=Heterozygous (PubMed=35944312).
CC   Omics: Array-based CGH.
CC   Miscellaneous: Has also a 16p13.11 duplication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=35944312
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D21S11: 29,30
ST   D5S818: 9,10
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1VE ! PNUi003-A
OI   CVCL_C1VG ! PNUi003-C
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=35944312; DOI=10.1016/j.scr.2022.102884;
RA   Okumura H., Arioka Y., Kushima I., Mori D., Ozaki N.;
RT   "Establishment of induced pluripotent stem cells from a patient with
RT   16p13.11 duplication and VPS13B deletion.";
RL   Stem Cell Res. 64:102884-102884(2022).
//